SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery

Core Viewpoint - SS Innovations International, Inc. successfully completed the world's first intercontinental robotic cardiac telesurgery, demonstrating the advanced capabilities of its SSi Mantra 3 surgical robotic system and paving the way for improved access to complex cardiac care globally [1][4]. Company Achievements - The cardiac procedure performed was a robotic atrial septal defect closure, conducted remotely from Strasbourg, France, to Indore, India, over a distance of more than 4,000 miles [2]. - A total of 35 telesurgeries, including 10 cardiac procedures, have been successfully completed using the SSi Mantra surgical robotic system, showcasing its effectiveness in complex surgeries [5]. - The SSi Mantra system has been clinically validated in over 100 different types of surgical procedures in India, with more than 5,000 multi-specialty surgeries performed without device-related adverse events [5][9]. Technological Innovation - The SSi Mantra surgical robotic system features a modular design with 3 to 5 robotic arms, a 3D 4K monitor, and advanced imaging capabilities, enhancing the safety and efficiency of surgical procedures [9]. - The system's telesurgery capabilities address traditional barriers related to travel, time, cost, and surgical accessibility, aiming to create a more equitable medical standard [4]. Regulatory Approval - SS Innovations is the only surgical robotic company to receive regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for both teleproctoring and telesurgery, highlighting its compliance with safety and efficacy standards [6].